Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.1700 (0.98%) ($5.1700 - $5.1700) on Mon. Jun. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.81% (three month average) | RSI | 47 | Latest Price | $5.1700(0.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(39%) IBB(37%) ARKK(35%) ARKG(34%) XAR(32%) | Factors Impacting ATRA price | ATRA will decline at least -2.405% in a week (0% probabilities). VIXM(-37%) VXX(-28%) UNG(-24%) USO(-19%) XOP(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.405% (StdDev 4.81%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.03(2.78%) | 10 Day Moving Average | $4.98(3.82%) | 20 Day Moving Average | $5.14(0.58%) | To recent high | -47.6% | To recent low | 10.2% | Market Cap | $384m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |